Is Hydrochlorothiazide (HCTZ) a sulfa drug?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Hydrochlorothiazide (HCTZ) is a sulfa drug, but it is a non-antimicrobial sulfonamide, which has a low risk of cross-reactivity with sulfonamide antimicrobials.

Key Points

  • HCTZ is classified as a thiazide diuretic, which is a type of non-antimicrobial sulfonamide 1.
  • Non-antimicrobial sulfonamides, such as HCTZ, have a low risk of cross-reactivity with sulfonamide antimicrobials due to their different chemical structure 1.
  • The risk of cross-reactivity is minimal, and HCTZ can be used in patients with a history of sulfonamide antimicrobial adverse reactions, unless they have a specific allergy to HCTZ itself 1.
  • Some studies suggest that patients with a history of sulfonamide allergy can tolerate HCTZ, but caution is still advised 1.

Evidence

  • A 2022 practice parameter update on drug allergy states that HCTZ is a non-antimicrobial sulfonamide with no or weak evidence of cross-reactivity in patients with a history of sulfonamide antimicrobial adverse reactions 1.
  • A study on guidelines for using antiretroviral agents among HIV-infected adults and adolescents mentions that amprenavir, a sulfonamide, should be used with caution in patients with a history of sulfa allergies, but does not provide information on HCTZ specifically 1.
  • Other studies on treating opportunistic infections and resistance testing of meningococci do not provide relevant information on HCTZ or its cross-reactivity with sulfonamide antimicrobials 1.
  • A 2021 review on adverse effects of medications on micronutrient status discusses the effects of thiazide diuretics, including HCTZ, on bone health, but does not address the issue of cross-reactivity with sulfonamide antimicrobials 1.

From the FDA Drug Label

WARNINGS Acute Myopia and Secondary Angle-Closure Glaucoma: Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma. CONTRAINDICATIONS Hydrochlorothiazide capsules are contraindicated in patients with anuria. Hypersensitivity to this product or other sulfonamide derived drugs is also contraindicated.

Yes, Hydrochlorothiazide (HCTZ) is a sulfa drug, as it is a sulfonamide derivative 2 and 2.

From the Research

Definition and Classification of Hydrochlorothiazide

  • Hydrochlorothiazide (HCTZ) is a sulfonamide-containing drug, as stated in the study published in 2009 3.
  • It belongs to the class of diuretic agents, specifically a thiazide-type diuretic, as mentioned in the study published in 2018 4 and 2016 5.
  • HCTZ is used in the treatment of hypertensive patients, as noted in the studies published in 2009 3, 2016 5, and 2015 6.

Relationship between HCTZ and Sulfa Drugs

  • HCTZ contains a sulfonamide group, which is also present in sulfa antibiotics, as mentioned in the studies published in 2009 3 and 2006 7.
  • However, the mechanism of allergic reactions to HCTZ is unlikely to be cross-sensitivity between sulfonamide antibiotics and sulfonamide nonantibiotic drugs, as stated in the study published in 2009 3.
  • There have been reports of patients with a history of hypersensitivity reactions to sulfonamide antibiotics experiencing allergic-like reactions to HCTZ, as described in the studies published in 2006 7 and 2015 6.

Adverse Reactions and Side Effects

  • HCTZ has been associated with various adverse effects, including electrolyte abnormalities, orthostatic hypotension, hyperglycemia, and photosensitivity, as mentioned in the study published in 2009 3.
  • Rare but serious drug complications, such as interstitial pneumonitis, angioedema, and aplastic anemia, have also been reported, as stated in the study published in 2009 3.
  • Other reported side effects include acute respiratory distress syndrome, as described in the study published in 2018 4, and myopericarditis, as reported in the study published in 2015 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.